西点药业 (301130)
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 7649.47
- Circulating A-Shares(W): 5841.31
- Earnings Per Share(RMB): 0.4333
- Net Assets Per Share(RMB): 11.9843
- Operating Revenue(W RMB): 18894.54
- Total Profit(W RMB): 3616.44
- Net Profit Attributable to Parent(W RMB): 3314.64
- Net Profit Growth Rate(%): -2.70
- Weighted Return on Equity(%): 3.6300
- Operating Cash Flow Per Share(RMB): 0.5030
- Undistributed Profit Per Share(RMB): 5.2941
- Capital Reserve Per Share(RMB): 4.7533
2. Main Business
The main business covers:
- Research and development of chemical drug APIs and preparations
- Production of chemical drug APIs and preparations
- Sales of chemical drug APIs and preparations
3. Company Basic Information
- Company Name: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
- Listing Date: 2022-02-23
- Industry: Pharmaceutical Manufacturing
- Address: No. 777 Xidian Avenue, Economic Development Zone, Panshi City, Jilin Province
- Website: www.xidianyy.com
- Company Profile：The joint-stock company was established in December 2001 by absorbing and merging a subsidiary and simultaneously undergoing a complete transformation. According to the "Approval of the People's Government of Jilin Province on Agreeing to the Absorption and Merger of Jilin Province Xidian Pharmaceutical Co., Ltd. by Jilin Province Tianhua Pharmaceutical Co., Ltd. and Its Change to Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.", after the company's predecessor, Jilin Province Tianhua Pharmaceutical Co., Ltd., absorbed and merged its controlling subsidiary, 35 natural person shareholders including Zhang Jun acted as promoters to wholly change Jilin Province Tianhua Pharmaceutical Co., Ltd. into a joint-stock company based on its audited net assets as of October 31, 2001. On November 9, 2001, Zhonghongxin Jianyuan Certified Public Accountants Co., Ltd. issued the Zhonghongxin Jianyuan Audit No. [2001] 261 "Audit Report". As of October 31, 2001, the owner's equity of Tianhua Pharmaceutical was 43,907,505.65 yuan. On November 20, 2001, the company held its founding meeting. All shareholders converted the audited book net assets of Tianhua Pharmaceutical as of October 31, 2001, amounting to 43,907,505.65 yuan, into 43,907,505.65 promoter shares at a 1:1 ratio, establishing Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd. by promotion. On December 12, 2001, Zhonghongxin Jianyuan Certified Public Accountants Co., Ltd. issued the Zhonghongxin Jianyuan Verification No. [2001] 60 "Capital Verification Report". On December 20, 2001, the issuer completed the industrial and commercial change registration, and the Jilin Provincial Administration for Industry and Commerce issued the "Business License" to the company. The unified social credit code is 912202011239483018.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Dingdian Investment Management (Beijing) Co., Ltd. - Hengqin Dingdian Equity Investment Fund Partnership (Limited Partnership) | Asset Management Plan | 601.32 | 10.29 |
| 2 | Zhuhai Hengqin Yanhe Health Technology Co., Ltd. | General Legal Person | 369.74 | 6.33 |
| 3 | Dingdian Investment Management (Beijing) Co., Ltd. - Hengqin Runhuiyi Equity Investment Fund Partnership (Limited Partnership) | General Legal Person | 310.67 | 5.32 |
| 4 | SDIC High-Tech Investment Co., Ltd. | General Legal Person | 248.40 | 4.25 |
| 5 | Shanghai Axing Investment Management Co., Ltd. - Axing Xingren No. 2 Private Securities Investment Fund | Private Securities Investment Fund | 140.04 | 2.40 |
| 6 | Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Quanying No. 66 Private Securities Investment Fund | Private Securities Investment Fund | 136.23 | 2.33 |
| 7 | Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Quanying No. 16 Private Securities Investment Fund | Private Securities Investment Fund | 75.74 | 1.30 |
| 8 | Yimin Core Growth Flexible Allocation Hybrid Securities Investment Fund | Fund | 0.92 | 0.02 |
5. Concept Sectors
- Infant and Child Concept
- Elderly Care Concept
- Immunotherapy
- Vitamin
- Hepatitis Concept
- Innovative Drug
- Margin Trading and Securities Lending
- Micro-Cap Stock
- Commitment Not to Reduce Holdings
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information